Skip Navigation U.S. Department of Health and Human Services www.hhs.gov/
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov/

Treating Tobacco Use and Dependence

Slide Presentation (Full Set)



For public use, these slides are based on the Public Health Service (PHS)-Sponsored Clinical Practice Guideline—Treating Tobacco Use and Dependence: 2008 Update. They include all tables, figures, meta-analyses, and recommendations contained in this clinical practice guideline.

Select to download the PowerPoint® slides (4.1 MB; Text Version). Plugin Software Help.


Treating Tobacco Use and Dependence: 2008 Update (Text Version of Slide Presentation)

  1. Treating Tobacco Use and Dependence: 2008 Update
  2. 2008 PHS Clinical Practice Guideline Update: Treating Tobacco Use and Dependence
  3. Index to Slides
  4. Index to Slides (Continued)
  5. History
  6. History
  7. Development Process
  8. Development Process
  9. Funded by:
  10. Panel Members
  11. PHS Liaisons
  12. Guideline Update Development Phases
  13. Development Process
  14. Development Process (Continued)
  15. Development Process (Continued)
  16. Development Process (Continued)
  17. Development Process (Continued)
  18. Development Process (Continued)
  19. Final Selected Topics
  20. Final Selected Topics (Continued)
  21. Topics Meta-Analyzed for the 2008 Guideline Update
  22. Topics Meta-Analyzed for the 2008 Guideline Update (Continued)
  23. Topics Meta-Analyzed for the 1996 and 2000 Guidelines and Included in the 2008 Guideline Update (But Not Re-Analyzed)
  24. Topics Meta-Analyzed for the 1996 and 2000 Guidelines and Included in the 2008 Guideline Update (But Not Re-Analyzed) (Continued)
  25. Topics Meta-Analyzed for the 1996 and 2000 Guidelines and Included in the 2008 Guideline Update (But Not Re-Analyzed) (Continued)
  26. Inclusion Criteria for Articles in a Meta-Analysis
  27. Summary of Strength of Evidence for Recommendations
  28. 10 Key Recommendations
  29. Ten Key Guideline Recommendations
  30. Ten Key Guideline Recommendations (Continued)
  31. Ten Key Guideline Recommendations (Continued)
  32. Ten Key Guideline Recommendations (Continued)
  33. Ten Key Guideline Recommendations (Continued)
  34. What's New in 2008?
  35. What's New in 2008? (Continued)
  36. What's New in 2008? (Continued)
  37. What's New in 2008? (Continued)
  38. What's New in 2008?-New Recommendations
  39. What's New in 2008?-New Recommendations (Continued)
  40. What's New in 2008?-New Recommendations (Continued)
  41. What's New in 2008?-New Recommendations (Continued)
  42. What's New in 2008?-New Recommendations (Continued)
  43. What's New in 2008?-New Recommendations (Continued)
  44. What's New in 2008?-New Recommendations (Continued)
  45. What's New in 2008? 2000 Recommendations Changed for 2008
  46. What's New in 2008? 2000 Recommendations Changed for 2008 (Continued)
  47. What's New in 2008? 2000 Recommendations Changed for 2008 (Continued)
  48. What's New in 2008? 2000 Recommendations Changed for 2008 (Continued)
  49. What's New in 2008? 2000 Recommendations Changed for 2008 (Continued)
  50. What's New in 2008? 2000 Recommendations Changed for 2008 (Continued)
  51. What's New in 2008? 2000 Recommendations Changed for 2008 (Continued)
  52. What's New in 2008? 2000 Recommendations Changed for 2008 (Continued)
  53. What's New in 2008? 2000 Recommendations Changed for 2008 (Continued)
  54. What's New in 2008? 2000 Recommendations Changed for 2008 (Continued)
  55. Conceptual Models
  56. Algorithm for Treating Tobacco Use
  57. Model for Treating Tobacco Use and Dependence
  58. The 5 As: Treating Tobacco as a Chronic Disease
  59. The "5 A's" Model for Treating Tobacco Use and Dependence
  60. For the Patient Willing To Quit
  61. For the Patient Willing To Quit
  62. For the Patient Willing To Quit (Continued)
  63. For the Patient Willing To Quit (Continued)
  64. For the Patient Willing To Quit (Continued)
  65. For the Patient Willing To Quit (Continued)
  66. For the Patient Willing To Quit (Continued)
  67. For the Patient Willing To Quit (Continued)
  68. For the Patient Willing To Quit (Continued)
  69. For the Patient Unwilling To Quit
  70. For the Patient Unwilling To Quit
  71. For the Patient Unwilling To Quit (Continued)
  72. For the Patient Unwilling To Quit (Continued)
  73. For the Patient Unwilling To Quit (Continued)
  74. For the Patient Unwilling To Quit (Continued)
  75. For the Patient Who Has Recently Quit
  76. For the Patient Who Has Recently Quit (Continued)
  77. For the Patient Who Has Recently Quit (Continued)
  78. Treatment Recommendations: Counseling
  79. Treatment Recommendations: Counseling (Continued)
  80. Treatment Recommendations: Counseling (Continued)
  81. Treatment Recommendations: Counseling (Continued)
  82. Treatment Recommendations: Counseling (Continued)
  83. Treatment Recommendations: Counseling (Continued)
  84. Treatment Recommendations: Counseling (Continued)
  85. Treatment Recommendations: Counseling (Continued)
  86. Treatment Recommendations: Counseling (Continued)
  87. Treatment Recommendations: Counseling (Continued)
  88. Treatment Recommendations: Counseling (Continued)
  89. Treatment Recommendations: Counseling (Continued)
  90. Treatment Recommendations: Counseling (Continued)
  91. Treatment Recommendations: Counseling (Continued)
  92. Treatment Recommendations: Counseling (Continued)
  93. Treatment Recommendations: Counseling (Continued)
  94. Treatment Recommendations: Counseling (Continued)
  95. Treatment Recommendations: Counseling (Continued)
  96. Treatment Recommendations: Counseling (Continued)
  97. Treatment Recommendations: Counseling (Continued)
  98. Treatment Recommendations: Counseling (Continued)
  99. Treatment Recommendations: Counseling (Continued)
  100. Treatment Recommendations: Counseling (Continued)
  101. Treatment Recommendations: Counseling (Continued)
  102. Treatment Recommendations: Counseling (Continued)
  103. Treatment Recommendations: Counseling (Continued)
  104. Treatment Recommendations: Counseling (Continued)
  105. Treatment Recommendations: Counseling (Continued)
  106. Treatment Recommendations: Counseling (Continued)
  107. Treatment Recommendations: Counseling (Continued)
  108. Treatment Recommendations: Counseling (Continued)
  109. Treatment Recommendations: Counseling (Continued)
  110. Treatment Recommendations: Counseling (Continued)
  111. Treatment Recommendations: Counseling (Continued)
  112. Treatment Recommendations: Counseling (Continued)
  113. Treatment Recommendations: Counseling (Continued)
  114. Treatment Recommendations: Counseling (Continued)
  115. Treatment Recommendations: Counseling (Continued)
  116. Treatment Recommendations: Counseling (Continued)
  117. Treatment Recommendations: Medication
  118. Treatment Recommendations: Medication
  119. Treatment Recommendations: Medications (Continued)
  120. Treatment Recommendations: Medications (Continued)
  121. Treatment Recommendations: Medications (Continued)
  122. Treatment Recommendations: Medications (Continued)
  123. Treatment Recommendations: Medications (Continued)
  124. Treatment Recommendations: Medications (Continued)
  125. Treatment Recommendations: Medications (Continued)
  126. Treatment Recommendations: Medications (Continued)
  127. Treatment Recommendations: Medications (Continued)
  128. Treatment Recommendations: Medications (Continued)
  129. Treatment Recommendations: Medications (Continued)
  130. Treatment Recommendations: Medications—Bupropion
  131. Treatment Recommendations: Medications
  132. Treatment Recommendations: Medications—Nicotine Gum
  133. Treatment Recommendations: Medications—Nicotine Gum (Continued)
  134. Treatment Recommendations: Medications
  135. Treatment Recommendations: Medications—Nicotine Inhaler
  136. Treatment Recommendations: Medications—Nicotine Inhaler (Continued)
  137. Treatment Recommendations: Medications
  138. Treatment Recommendations: Medications—Nicotine Lozenge
  139. Treatment Recommendations: Medications—Nicotine Lozenge (continued)
  140. Treatment Recommendations: Medications
  141. Treatment Recommendations: Medications (Continued)
  142. Treatment Recommendations: Medications—Nicotine Nasal Spray
  143. Treatment Recommendations: Medications—Nicotine Nasal Spray (continued)
  144. Treatment Recommendations: Medications
  145. Treatment Recommendations: Medications—Nicotine Patch
  146. Treatment Recommendations: Medications—Nicotine Patch (continued)
  147. Treatment Recommendations: Medications
  148. Treatment Recommendations: Medications—Varenicline
  149. Treatment Recommendations: Medications—Varenicline (continued)
  150. Treatment Recommendations: Medications
  151. Treatment Recommendations: Medications—Clonidine
  152. Treatment Recommendations: Medications—Clonidine (Continued)
  153. Treatment Recommendations: Medications
  154. Treatment Recommendations: Medications—Nortriptyline
  155. Treatment Recommendations: Medications—Nortriptyline (Continued)
  156. Treatment Recommendations: Medications
  157. Treatment Recommendations: Medications—Relative Effectiveness
  158. Treatment Recommendations: Medications—Relative Effectiveness (Continued)
  159. Treatment Recommendations: Medications—Relative Effectiveness (Continued)
  160. Treatment Recommendations: Medications
  161. Treatment Recommendations: Medications—Over the Counter Medications
  162. Treatment Recommendations: Medications—Over the Counter Medications (Continued)
  163. Treatment Recommendations: Medications—Over the Counter Medications (Continued)
  164. Treatment Recommendations: Intensive Treatment
  165. Treatment Recommendations: Intensive Treatment (Continued)
  166. Components of Intensive Treatment
  167. Components of Intensive Treatment (Continued)
  168. Components of Intensive Treatment (Continued)
  169. Systems
  170. System Strategies
  171. Systems Strategy 1. Implement a tobacco-user identification system in every clinic
  172. Systems Strategy 2. Provide education, resources, and feedback to promote provider intervention
  173. Systems Strategy 3. Dedicate staff to provide tobacco dependence treatment and assess the delivery of this treatment in staff performance evaluations
  174. Systems Strategy 4. Promote hospital policies that support and provide inpatient tobacco dependence services
  175. Systems Strategy 5. Include tobacco dependence treatments (both counseling and medication) .identified as effective in this Guideline, as paid or covered services for all subscribers or .members of health insurance packages
  176. Systems—Clinician Training and Reminder Systems
  177. Systems—Clinician Training and Reminder Systems (Continued)
  178. Systems—Clinician Training and Reminder Systems (Continued)
  179. Systems—Clinician Training and Reminder Systems (Continued)
  180. Systems—Clinician Training and Reminder Systems (Continued)
  181. Systems—Clinician Training and Reminder Systems (Continued)
  182. Systems—Clinician Training and Reminder Systems (Continued)
  183. Systems—Cost-Effectiveness of Tobacco Dependence Interventions
  184. Systems—Tobacco Dependence Treatment as a Part of Assessing Healthcare Quality
  185. Systems—Providing Treatment for Tobacco Use and Dependence as a Covered Benefit
  186. Systems—Providing Treatment for Tobacco Use and Dependence as a Covered Benefit Recommendation
  187. Systems—Providing Treatment for Tobacco Use and Dependence as a Covered Benefit Recommendation (Continued)
  188. Systems—Providing Treatment for Tobacco Use and Dependence as a Covered Benefit Recommendation (Continued)
  189. Specific Populations and Other Topics
  190. Specific Populations and Other Topics
  191. Specific Populations and Other Topics (Continued)
  192. Specific Populations and Other Topics (Continued)
  193. Specific Populations and Other Topics (Continued)
  194. Specific Populations and Other Topics (Continued)
  195. Specific Populations and Other Topics (Continued)
  196. Specific Populations and Other Topics (Continued)
  197. Specific Populations and Other Topics (Continued)
  198. Specific Populations and Other Topics (Continued)
  199. Specific Populations and Other Topics (Continued)
  200. Specific Populations and Other Topics (Continued)
  201. Specific Populations and Other Topics (Continued)
  202. Specific Populations and Other Topics (Continued)
  203. Specific Populations and Other Topics (Continued)
  204. Specific Populations and Other Topics (Continued)
  205. Specific Populations and Other Topics (Continued)
  206. Specific Populations and Other Topics - Pregnant Smokers
  207. Specific Populations and Other Topics - Pregnant Smokers (Continued)
  208. Specific Populations and Other Topics - Pregnant Smokers (Continued)
  209. Specific Populations and Other Topics - Pregnant Smokers (Continued)
  210. Specific Populations and Other Topics - Pregnant Smokers (Continued)
  211. Specific Populations and Other Topics (Continued)
  212. Specific Populations and Other Topics — Weight Gain(Continued)
  213. Specific Populations and Other Topics (Continued)
  214. Specific Populations and Other Topics (Continued)
  215. Helpful Web Sites
  216. Helpful Web Sites (All Web sites listed are either government-sponsored organizations or nonprofit foundations)
  217. Helpful Web Sites (All Web sites listed are either government-sponsored organizations or nonprofit foundations) (Continued)
  218. Helpful Web Sites (All Web sites listed are either government-sponsored organizations or nonprofit foundations) (Continued)
  219. Helpful Web Sites (All Web sites listed are either government-sponsored organizations or nonprofit foundations) (Continued)
  220. Helpful Web Sites (All Web sites listed are either government-sponsored organizations or nonprofit foundations) (Continued)
  221. Obtaining the 2008 Guideline
  222. Obtaining the 2008 Guideline (Continued)

Current as of June 2009


Internet Citation:

Treating Tobacco Use and Dependence: 2008 Update. Slide presentation (Full Set). Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/tobacco/slides/tobaccoslides.htm


 

AHRQAdvancing Excellence in Health Care